Main > ONCOLOGY (**) > Pancreas Cancer *** > Treatment. > Co: USA. E. Gemcitabine.HCl Inj.

---

Co: USA. E. Gemcitabine.HCl Inj.'s subsections
(*) USA 1st Approval Year: 1996
Company
Nucleoside Analog
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2008. 10.14.
Patent>USA Expiration: 2010. 05.15.
TradeMark
TradeMark Web-Site

Co: USA. E. Gemcitabine.HCl Inj.'s products
This section has no products